INmune Bio Inc. (NASDAQ:INMB) saw its stock plunge 60% in premarket trading Monday, following the release of mixed data from its Phase 2 MINDFuL trial evaluating XPro, a therapy aimed at treating ...

Mayo Clinic's FDA-approved blood test diagnoses Alzheimer's disease with 95% accuracy, offering a less invasive alternative to traditional methods.

The blood test is significantly less expensive and invasive than other tests for diagnosing Alzheimer's, opening the door for early interventions.

Anavex’ lead drug candidate, Anavex 2-73 (blarcamesine), has successfully completed Phase 2a and a Phase 2b/3 clinical trials for Alzheimer's disease.

Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational drug, riliprubart, for the treatment of antibody-mediated rejection (AMR) in solid organ transplantation.

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.

UCLA researchers have developed a drug that counteracts the impaired cognition caused by Alzheimer’s disease and reestablishes brain connections following strokes in mice. The team began ...

CNN Editorial Research (CNN) — Here is a look at Alzheimer’s disease, a progressive brain disorder that leads to loss of memory and other intellectual abilities. Facts Alzheimer’s disease is ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

Sanofi's riliprubart gets FDA orphan drug status for organ transplant rejection, unlocking key development perks.